| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.52 | 0.06 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | -0.29 | 0.02 |
| mRNA | RDEA119 | FIMM | pan-cancer | AAC | -0.26 | 0.1 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | -0.22 | 0.2 |
| mRNA | AZD6244 | FIMM | pan-cancer | AAC | -0.22 | 0.2 |
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | -0.18 | 0.3 |
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | -0.18 | 0.3 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | -0.16 | 9e-07 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.2 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | -0.14 | 3e-05 |